{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:18:29Z","timestamp":1793305109464,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.atherosclerosis.2025.120390","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:02:06Z","timestamp":1748862126000},"page":"120390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study"],"prefix":"10.1016","volume":"407","author":[{"given":"Jheng-Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1723-828X","authenticated-orcid":false,"given":"Yu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120390_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2025.120390_bib2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.120390_bib3","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"9438","key":"10.1016\/j.atherosclerosis.2025.120390_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120390_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120390_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.hrtlng.2018.05.006","article-title":"Psychosocial assessment and intervention - are we doing enough?","volume":"47","author":"Thompson","year":"2018","journal-title":"Heart Lung"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120390_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/09540261.2017.1357540","article-title":"Panic disorder and cardiovascular diseases: an overview","volume":"29","author":"Machado","year":"2017","journal-title":"Int Rev Psychiatr"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120390_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11920-016-0739-5","article-title":"Anxiety disorders and cardiovascular disease","volume":"18","author":"Celano","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120390_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5001\/omj.2017.04","article-title":"Quality of life in patients with coronary artery disease and panic disorder: a comparative study","volume":"32","author":"Srivastava","year":"2017","journal-title":"Oman Med J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120390_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/JCN.0b013e318292b235","article-title":"Anxiety and adverse health outcomes among cardiac patients: a biobehavioral model","volume":"29","author":"Abed","year":"2014","journal-title":"J Cardiovasc Nurs"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120390_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.genhosppsych.2015.03.022","article-title":"Depression and anxiety disorders and the link to physician diagnosed cardiac disease and metabolic risk factors","volume":"37","author":"Kinley","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120390_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ajh\/hpv047","article-title":"State of the art review: depression, stress, anxiety, and cardiovascular disease","volume":"28","author":"Cohen","year":"2015","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120390_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14656566.2018.1491966","article-title":"Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review","volume":"19","author":"Strawn","year":"2018","journal-title":"Expet Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120390_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British association for psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120390_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00392-020-01697-8","article-title":"The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis","volume":"110","author":"Fernandes","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2025.120390_bib16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120390_bib17","article-title":"Anxiety as a risk factor for postoperative delirium in elective spine deformity surgeries: a national database study","volume":"14","author":"Freedman","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120390_bib18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jmii.2023.09.005","article-title":"Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism","volume":"56","author":"Wu","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.120390_bib19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120390_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1198\/000313001317097960","article-title":"On judging the significance of differences by examining the overlap between confidence intervals","volume":"55","author":"Schenker","year":"2001","journal-title":"Am Statistician"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120390_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120390_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12350-019-01624-z","article-title":"Landmark analysis: a primer","volume":"26","author":"Morgan","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120390_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1192\/bjp.bp.114.156554","article-title":"Anxiety and new onset of cardiovascular disease: critical review and meta-analysis","volume":"208","author":"Batelaan","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120390_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.amjcard.2016.05.041","article-title":"Meta-Analysis of anxiety as a risk factor for cardiovascular disease","volume":"118","author":"Emdin","year":"2016","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120390_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jacc.2010.03.034","article-title":"Anxiety and risk of incident coronary heart disease: a meta-analysis","volume":"56","author":"Roest","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120390_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archgenpsychiatry.2010.74","article-title":"Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:the heart and soul study","volume":"67","author":"Martens","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120390_bib27","first-page":"32","article-title":"Anxiety and cardiovascular risk: Review of epidemiological and clinical evidence","volume":"2","author":"Olafiranye","year":"2011","journal-title":"Mind Brain"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2025.120390_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jad.2011.02.023","article-title":"Prevalence and correlates of generalized anxiety disorder among older adults in the Australian National Survey of Mental Health and Well-Being","volume":"132","author":"Gon\u00e7alves","year":"2011","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120390_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","volume":"26","author":"Tynan","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120390_bib30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1503\/cmaj.111576","article-title":"Antidepressants, antiplatelets and bleeding: one more thing to worry about?","volume":"183","author":"Juurlink","year":"2011","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120390_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11883-016-0581-6","article-title":"Antiplatelet management for coronary heart disease: advances and challenges","volume":"18","author":"Gillette","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2025.120390_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jad.2022.08.007","article-title":"A systematic review and meta-analysis on the effect of selective serotonin reuptake inhibitors on endothelial function","volume":"316","author":"Delialis","year":"2022","journal-title":"J Affect Disord"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120390_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168969","article-title":"Functional impairment of Endothelial Colony Forming Cells (ECFC) in patients with severe atherosclerotic cardiovascular disease (ASCVD)","volume":"23","author":"Simoncini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120390_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2020.100319","article-title":"Outpatient and self-referred participants: adherence to treatment components and outcome in an internet intervention targeting anxiety disorders","volume":"20","author":"Arndt","year":"2020","journal-title":"Internet Interv"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120390_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062873","article-title":"Improving adherence and clinical outcomes in self-guided internet treatment for anxiety and depression: randomised controlled trial","volume":"8","author":"Titov","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120390_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/YIC.0b013e32835d735d","article-title":"Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure","volume":"28","author":"Andrade","year":"2013","journal-title":"Int Clin Psychopharmacol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025012882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025012882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:07:29Z","timestamp":1778944049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025012882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S0021915025012882"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120390","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120390"}}